Some shareholders might object, but there is little they could do, legal experts say.
Producer reveals last-minute decision not to get on helicopter before it crashed killing Oliver Tree and five others
Producer Victor Wao shared an image of his late friends captioned “I owe you my life” after U.S. alt-pop singer killed in Brazil crash
Sick vid shows bungee instructor pretending to throw body off bridge before ‘he pushed woman to her death without rope’
ONE of the bungee instructors who allegedly threw a woman 130ft to her death joked about launching bodies off the same bridge in a sick stunt. Maria Eduarda Rodrigues de Freitas, 21, was sent plummeting to her death on Saturday when she was hurled off …
Pressure on Trump as critics say peace deal just buys Iran time to build nuke
Deal amounts to a colossal reward for a regime that has spent decades executing dissidents, sponsoring terrorism and destabilising the Middle East.
Macron deploys Versailles’ gold, mirrors and history in a high-stakes courtship of Trump
Donald Trump explained the appeal in one sentence: “Versailles is not gold leaf – Versailles is the real deal.”
Macron deploys Versailles’ gold, mirrors and history in a high-stakes courtship of Trump
French President Emmanuel Macron is opening the gilded gates of Louis XIV’s palace to U.S. President Donald Trump for a private reception, show and dinner marking America’s 250th birthday
Why are experts warning latest Ebola outbreak could be ‘worst ever’?
The virus is spreading faster than health workers can track it and international funding has slumped.
Serial killer who murdered eight women in Long Island town imprisoned for life
In fiery exchange, judge sentenced him to three life sentences plus 25 years to life on four other charges, all running consecutively.
Finland Lifts a Nuclear Device Ban, Eyeing an Uncertain World
The Nordic country, which shares an 830-mile border with Russia, said the move would strengthen the NATO alliance, which it joined three years ago.
UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.